Skip to content

A randomized controlled study for the safety and efficacy of rimazolam toluenesulfonate in induction and maintenance of general anesthesia

Study on the safety and efficacy of rimazolam toluenesulfonate in induction and maintenance of general anesthesia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034881
Enrollment
Unknown
Registered
2020-07-22
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients under general anesthesia

Interventions

Ramazolam group (R group):Ramazolam
Propofol group (group B) :Propofol

Sponsors

Department of Anesthesiology, Jingzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) the clinical data are accurate and complete; (2) the age is 18-65 years old, male or female. (3) No major organ dysfunction such as liver and kidney, no shock and cardiopulmonary dysfunction. (4) General anesthesia.ASA grade is I ~ II; (5) have the ability of reading and comprehension; know about this study and participate voluntarily. (6) lower abdominal surgery within 2 hours, such as laparoscopy, hysteroscopy and cystoscope.

Exclusion criteria

Exclusion criteria: (1) patients with severe cardiovascular disease; (2) patients with mental disorders; (3) BMI "35kg Universe M2 politics; (4) pregnant women; (5) lactating women; (6) failure to follow up, drop out of the study due to personal factors, and (7) patients who are allergic to drugs in this study; (8) history of taking benzodiazepines and other sedative drugs; (9) patients with communication disorders.

Design outcomes

Primary

MeasureTime frame
NI index;Vital signs;Time of loss of consciousness;Awakening time;TOF;

Countries

China

Contacts

Public ContactRui Xia

Jingzhou First People's Hospital

879560350@qq.com+86 18972161338

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026